Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0300
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST
Firebrick Pharma Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 0.11 | 0.29 | 0.01 | 0 | 0 |
Other Revenue | 0.03 | 0.22 | 2.74 | 0.02 | 1.08 |
| 0.14 | 0.52 | 2.75 | 0.02 | 1.08 | |
Revenue Growth | -73.69% | -81.26% | 12096.48% | -97.92% | 156.72% |
Cost of Revenue | 0.17 | 0.24 | 0.04 | - | - |
Gross Profit | -0.03 | 0.28 | 2.71 | 0.02 | 1.08 |
Selling, General & Admin | 1.93 | 1.84 | 1.75 | 2.48 | 1.92 |
Research & Development | 0.55 | 0.74 | 1.91 | 4.09 | 2.22 |
Other Operating Expenses | 0.24 | 0.17 | 0.14 | 0.19 | 0.14 |
Operating Expenses | 2.94 | 2.81 | 3.8 | 6.77 | 4.59 |
Operating Income | -2.97 | -2.54 | -1.09 | -6.75 | -3.51 |
Interest Expense | - | - | -0 | - | -0 |
Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0.04 | 0 |
Other Non Operating Income (Expenses) | -0.1 | -0.1 | -0.1 | -0.09 | -0.28 |
Pretax Income | -3.06 | -2.63 | -1.18 | -6.8 | -3.8 |
Net Income | -3.06 | -2.63 | -1.18 | -6.8 | -3.8 |
Net Income to Common | -3.06 | -2.63 | -1.18 | -6.8 | -3.8 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 254 | 210 | 179 | 170 | 117 |
Shares Outstanding (Diluted) | 254 | 210 | 179 | 170 | 117 |
Shares Change | 20.96% | 17.46% | 5.25% | 45.98% | 5.45% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.04 | -0.03 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -2.6 | -1.86 | -2.35 | -5.78 | -4.23 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.04 |
Gross Margin | -25.01% | 53.42% | 98.64% | 100.00% | 100.00% |
Operating Margin | -2190.10% | -492.61% | -39.70% | -29941.76% | -323.93% |
Profit Margin | -2258.82% | -511.04% | -42.75% | -30164.40% | -350.42% |
Free Cash Flow Margin | -1919.99% | -361.23% | -85.26% | -25653.98% | -390.90% |
EBITDA | -2.97 | -2.53 | -1.08 | -6.74 | -3.5 |
EBITDA Margin | - | - | -39.44% | - | - |
D&A For EBITDA | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
EBIT | -2.97 | -2.54 | -1.09 | -6.75 | -3.51 |
EBIT Margin | - | - | -39.70% | - | - |